Northstar Wealth Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$5.83M Sell
167,343
-2,904
-2% -$102K 2.72% 5
2020
Q2
$5.28M Buy
170,247
+306
+0.2% +$10.4K 2.21% 8
2020
Q1
$5.26M Buy
169,941
+679
+0.4% +$23.1K 2.67% 5
2019
Q4
$6.29M Buy
169,262
+46,976
+38% +$1.67M 2.58% 3
2019
Q3
$4.17M Sell
122,286
-992
-0.8% -$36.1K 1.83% 12
2019
Q2
$5.07M Buy
123,278
+198
+0.2% +$7.86K 2.26% 9
2019
Q1
$4.96M Buy
123,080
+1,052
+0.9% +$42.1K 2.27% 7
2018
Q4
$5.05M Buy
122,028
+1,278
+1% +$53.1K 2.65% 4
2018
Q3
$5.05M Buy
120,750
+10,468
+9% +$403K 2.42% 5
2018
Q2
$3.8M Sell
110,282
-2,102
-2% -$71.8K 1.9% 8
2018
Q1
$3.78M Buy
112,384
+54,850
+95% +$1.89M 1.93% 7
2017
Q4
$1.99M Buy
57,534
+2,768
+5% +$94.4K 1.77% 12
2017
Q3
$1.88M Sell
54,766
-10,995
-17% -$353K 1.83% 12
2017
Q2
$2.08M Sell
65,761
-2,201
-3% -$69.4K 1.9% 11
2017
Q1
$2.21M Buy
+67,962
New +$2.14M 2.05% 9

Other funds holding PFE

Northstar Wealth Partners's PFE Position: Q3 2020 in Review

Northstar Wealth Partners reduced its Pfizer (PFE) stake by 1.7% in Q3 2020, selling an estimated $102K and leaving 167,343 shares worth $5.83M. The position accounts for 2.72% of the portfolio, ranked #5.

Northstar Wealth Partners first reported a position in PFE in Q1 2017 and has held it in 15 quarters since. The position peaked at $6.29M in Q4 2019. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Northstar Wealth Partners held 167,343 shares of Pfizer worth $5.83M as of Q3 2020.
  • Northstar Wealth Partners sold 2,904 Pfizer shares in Q3 2020, an estimated $102K.
  • Pfizer made up 2.72% of Northstar Wealth Partners's portfolio in Q3 2020, its #5 holding.
  • Northstar Wealth Partners first reported a position in Pfizer in Q1 2017 and has held it in 15 quarters since.
  • Northstar Wealth Partners's Pfizer position peaked at $6.29M in Q4 2019.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.